Skip to content

A study to evaluate the effect of aloe vera and urea cream application on hand foot syndrome in a patients suffering from gastrointestinal cancer and receiving 5 fluorouracil ( capecitabine )chemotherapy .

Effects of topical application of urea and aloe vera cream on hand-foot syndrome in GI cancer patients receiving 5FU. A randomized controlled trail. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073897
Enrollment
160
Registered
2024-09-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: C16- Malignant neoplasm of stomach

Interventions

Intervention1: standard of care with Urea and aloe vera topical application: The participants randomized in the experimental arm will be given standard of care with tubes of urea and aloe-vera cream a

Sponsors

Tata Memorial Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age more than 18 years 2. Receiving 1st cycle of 5FU both oral(Capecitabine) and intravenous chemotherapy 3. Willing to participate and give written consent 4.Patient who can understand Hindi, Marathi, Bengali and English

Exclusion criteria

Exclusion criteria: 1 Patients having allergy to urea cream and aloe-vera.2 Patients with dermatological conditions that affect the hands or feet 3 Patients receiving targeted therapy. 4 Patients receiving radiation therapy.

Design outcomes

Primary

MeasureTime frame
Resolution of hand foot syndrome as assess by CTCAE version of 5.0Timepoint: At 3rd, 6th and 9th week .

Secondary

MeasureTime frame
To assess the safety of urea & aloe vera containing ointment on 3rd, 6th & 9th week of assessment .Timepoint: Assess at 3rd , 6th & 9th week;To find incidence of early onset of hand foot syndrome after receiving 5 FU containing chemotherapy . Timepoint: Assess at 3rd, 6th & 9th week .

Countries

India

Contacts

Public ContactMs Suchita Shekhar Mhatre

Tata Memorial Hospital

meeraachrekar@hotmail.com9769993848

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026